Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVETIRACETAM Cause Toxic skin eruption? 98 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 98 reports of Toxic skin eruption have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.2% of all adverse event reports for LEVETIRACETAM.

98
Reports of Toxic skin eruption with LEVETIRACETAM
0.2%
of all LEVETIRACETAM reports
2
Deaths
67
Hospitalizations

How Dangerous Is Toxic skin eruption From LEVETIRACETAM?

Of the 98 reports, 2 (2.0%) resulted in death, 67 (68.4%) required hospitalization, and 1 (1.0%) were considered life-threatening.

Is Toxic skin eruption Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 98 reports have been filed with the FAERS database.

What Other Side Effects Does LEVETIRACETAM Cause?

Seizure (9,961) Drug ineffective (8,666) Off label use (5,789) Maternal exposure during pregnancy (3,197) Foetal exposure during pregnancy (2,604) Epilepsy (2,546) Generalised tonic-clonic seizure (2,276) Somnolence (2,070) Fatigue (1,972) Status epilepticus (1,883)

What Other Drugs Cause Toxic skin eruption?

SULFAMETHOXAZOLE\TRIMETHOPRIM (367) ALLOPURINOL (291) AMOXICILLIN (291) PIPERACILLIN\TAZOBACTAM (263) VANCOMYCIN (250) PANTOPRAZOLE (233) CLINDAMYCIN (212) VALACYCLOVIR (207) CARBOPLATIN (194) LAMOTRIGINE (182)

Which LEVETIRACETAM Alternatives Have Lower Toxic skin eruption Risk?

LEVETIRACETAM vs LEVOBUNOLOL LEVETIRACETAM vs LEVOBUPIVACAINE LEVETIRACETAM vs LEVOCARNITINE LEVETIRACETAM vs LEVOCETIRIZINE LEVETIRACETAM vs LEVODOPA

Related Pages

LEVETIRACETAM Full Profile All Toxic skin eruption Reports All Drugs Causing Toxic skin eruption LEVETIRACETAM Demographics